FreedomWorks Opposes the Elijah E. Cummings Lower Drug Costs Now Act

WASHINGTON, D.C. — In response to the reintroduction of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, Adam Brandon, FreedomWorks President, commented:

“Last week, House Democrats introduced legislation to impose socialist price controls. Beyond the unprecedented level of government involvement in our healthcare space, the economics behind H.R. 3 are deeply flawed. Prices are a signal of what something is worth. Merely dictating that prices be different will not solve the underlying issue. It is a simplistic proposal to address a very complicated problem. Not only would this be a tacit admission that command-and-control, single-payer systems are somehow more effective, it would begin the process of importing the same inefficiencies of those systems to the U.S. For a problem that impacts so many, we cannot afford half-hearted proposals like this one.”